Support program for newly diagnosed acute leukemia patients
Part of Mental health clinical trials.
This study tests whether a formal support program can help people newly diagnosed with acute leukemia. If you're starting treatment at the Centre Henri Becquerel, this program may offer extra guidance and help improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with acute leukemia and have not started treatment yet.
- You are between 26 and 79 years old.
- You are being treated at the Centre Henri Becquerel hospital.
- You are a member of social security (or have a similar health coverage).
- You have not had cancer in the last 5 years (except for this new leukemia diagnosis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an emotion- and symptom-focused way of engaging with care for people who are newly diagnosed with acute leukemia and starting intensive “induction” treatment aimed at cure. It may help you feel better supported and better able to manage distressing symptoms during a critical early phase of treatment.
This study is beta-testing a new app designed to reduce healthcare disparities among people admitted to the hospital with suspected acute leukemia. Your feedback could help make the app more helpful for future patients.
This study is looking at blood and bone marrow samples from people with acute leukemia to understand how the immune system reacts to the disease and treatment. The goal is to find better ways to treat leukemia.
This study looks at how well a new program of supportive care (extra help for symptoms and well-being) works for people with cancer. It's open to anyone with any type or stage of cancer who has had a needs assessment.
This trial studies how screening for social needs (like housing, food, or transportation) and offering early help can improve care for adults with leukemia. It is for patients newly referred to a leukemia clinic.
This study tests a program that adds extra aging-related support to standard care for older adults with acute myeloid leukemia (AML) starting a type of treatment called venetoclax-based therapy. The goal is to see if this extra support improves quality of life and well-being.
Hear when a new Acute Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.